1. Immunotherapy in inflammatory bowel disease;Ahluwalia;Med. Clin. North Am.,2012
2. Methodological challenges in observational research: a pharmacoepidemiological perspective;Ali;Br. J. Pharmaceut. Res.,2013
3. Utilizing data consortia to monitor safety and effectiveness of biosimilars and their innovator products;AMCP Task Force on Biosimilar Collective Intelligence Systems;J. Manag. Care Spec. Pharm.,2015
4. Regulation of Biosimilar Medicines. Version 2.0, December 2015;Australian Government,2015
5. Development of a Crohn's disease activity index. National cooperative Crohn's disease study;Best;Gastroenterology,1976